➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Colorcon
Medtronic
McKinsey
Harvard Business School

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Captopril - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for captopril and what is the scope of patent protection?

Captopril is the generic ingredient in seven branded drugs marketed by Par Pharm, Ajanta Pharma Ltd, Annora Pharma, Apothecon, Boscogen, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan, Oxford Pharms, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Teva, Watson Labs, Wockhardt Ltd, Yaopharma Co Ltd, Ivax Sub Teva Pharms, and Vintage Pharms Llc, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for captopril. Thirteen suppliers are listed for this compound.

Drug Prices for captopril

See drug prices for captopril

Recent Clinical Trials for captopril

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of ParaíbaPhase 4
Case Comprehensive Cancer CenterPhase 1/Phase 2
Kafrelsheikh UniversityPhase 2

See all captopril clinical trials

Pharmacology for captopril
Medical Subject Heading (MeSH) Categories for captopril
Paragraph IV (Patent) Challenges for CAPTOPRIL
Tradename Dosage Ingredient NDA Submissiondate
CAPOTEN TABLET;ORAL captopril 018343

US Patents and Regulatory Information for captopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms CAPTOPRIL captopril TABLET;ORAL 074505-003 Feb 13, 1996 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Teva CAPTOPRIL captopril TABLET;ORAL 074322-001 Feb 13, 1996 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Cosette CAPTOPRIL captopril TABLET;ORAL 074433-003 Feb 13, 1996 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Par Pharm CAPTOPRIL captopril TABLET;ORAL 074493-001 Feb 13, 1996 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Boscogen CAPTOPRIL captopril TABLET;ORAL 074677-004 May 30, 1997 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Mylan CAPTOPRIL captopril TABLET;ORAL 074434-001 Feb 13, 1996 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Ivax Sub Teva Pharms CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 075055-004 Jun 18, 1998 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for captopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-001 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-002 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-005 Jan 17, 1985   Get Started for $10   Get Started for $10
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995   Get Started for $10   Get Started for $10
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-003 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-003 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-001 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Moodys
Colorcon
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.